The Centers for Disease Control and Prevention has launched an initiative aimed at more quickly identifying central-line-associated bloodstream infections in hospital patients.
CDC targeting central-line infections
According to CDC data, roughly 250,000 patients in the U.S. develop the infections annually, and they cost between $5,734 and $22,939 per patient to treat.
The CDC initiative, a joint research project with the healthcare quality-improvement and group-purchasing organization Premier and the Chicago Prevention Epicenter at John H. Stroger Jr. Hospital of Cook County, will also seek to automate reporting of central-line-associated infections. The initiative will use an electronic surveillance system that combines an infection-detection algorithm developed by researchers at the Chicago Prevention Epicenter with the current infection definition developed by the CDC's National Healthcare Safety Network to screen blood samples from patients at Premier's 2,300 member hospitals for potential infections.
Similar to the current surveillance system, providers will only screen patients who are suspected of having a bloodstream infection, but the screenings will be done using a high-speed electronic surveillance tool as opposed to manual surveillance by clinicians. The two-year project will test whether the combined infection definitions along with automated surveillance technology will help clinicians more quickly identify and treat central-line-associated bloodstream infections, a Premier spokesman said.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.